Geron Corporation

Geron Corporation is a biopharmaceutical company focused on developing treatments for cancer and other diseases by targeting telomerase, an enzyme that plays a significant role in cell division and growth. Their lead product, imetelstat, is designed to inhibit telomerase activity in cancer cells, potentially slowing down tumor growth. Geron’s research aims to address unmet medical needs, particularly in hematologic malignancies like myelofibrosis, a type of bone marrow cancer. The company is in the clinical trial phase for its treatments, seeking to bring innovative therapies to market for patients with serious health conditions.